Đang chuẩn bị liên kết để tải về tài liệu:
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer

Colorectal cancer (CRC) is the second leading cancer killer in the US today and patients with metastatic disease have only a 14% 5-year survival. One of the most impactful recent advances in cancer therapy, immune checkpoint inhibition, has not been shown to be effective for the majority of these patients. | Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer